1. Home
  2. PFSA vs XXII Comparison

PFSA vs XXII Comparison

Compare PFSA & XXII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PFSA

Profusa Inc.

N/A

Current Price

$0.52

Market Cap

3.7M

Sector

Health Care

ML Signal

N/A

Logo 22nd Century Group Inc.

XXII

22nd Century Group Inc.

N/A

Current Price

$3.55

Market Cap

3.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PFSA
XXII
Founded
2009
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medicinal Chemicals and Botanical Products
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.3M
IPO Year
N/A
2011

Fundamental Metrics

Financial Performance
Metric
PFSA
XXII
Price
$0.52
$3.55
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
213.1K
26.0K
Earning Date
04-02-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$25,832,530.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$79.56
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.05
$0.67
52 Week High
$4.22
$11.37

Technical Indicators

Market Signals
Indicator
PFSA
XXII
Relative Strength Index (RSI) 35.23 38.00
Support Level $0.46 $1.52
Resistance Level $0.66 $6.86
Average True Range (ATR) 0.10 0.24
MACD -0.06 -0.06
Stochastic Oscillator 16.76 7.34

Price Performance

Historical Comparison
PFSA
XXII

About PFSA Profusa Inc.

Profusa Inc is a clinical-stage digital health and medical technology company focused on developing biosensing solutions to improve health outcomes for patients with a variety of different diseases and conditions. The Company's technology enables the development of bioengineered sensors that are designed to become one with the body to detect and continuously transmit actionable, clinical-grade data for personal and medical use. The Company's first offering in the European Union, the Lumee Oxygen Platform, is designed to report reliable tissue oxygen levels at various regions of interest, both acutely and long-term.

About XXII 22nd Century Group Inc.

22nd Century Group Inc is a United States-based biotechnology company focused on utilizing alkaloid plant technologies to improve health and wellness with reduced nicotine tobacco, and hemp/cannabis. It has one operating segment; The tobacco segment is engaged in commercializing its proprietary VLNC tobacco plants and cigarette products, which contain nicotine than conventional tobacco and cigarettes, and research cigarettes sold under the brand name SPECTRUM. It derives a majority of its revenue from the tobacco segment.

Share on Social Networks: